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The Effects of Vitamin D levels on Osteoporosis and Osteopenia 
 
Executive Summary 
Problem 
Vitamin D deficiency is a concern, not only in the United States, but worldwide.  
Identifying a correlation for osteoporosis and osteopenia in vitamin D deficient patients may 
reduce the risk of osteoporosis-related fractures.  The PICO question for this capstone project 
was: In osteoporotic or osteopenic patients, what is the relationship between reduced serum 
levels of vitamin D OH 25 compared to normal serum levels of vitamin D OH 25, in the 
incidence of osteoporosis or osteopenia?  Osteoporosis contributes to fracture risk in patients, 
which subsequently has been shown to result from an insufficient level of vitamin D.   
 
Purpose 
The purpose of the project was to evaluate the relationship between osteoporosis and 
osteopenia and Vitamin D OH 25 levels.   
 
Goals and Objectives 
The goal of this study was to determine if a relationship existed between vitamin D 
deficiency and osteoporosis or osteopenia and note its clinical significance.  Identifying a 
correlation between these factors may help to raise awareness of the need for testing of 
vitamin D levels in the investigator’s practice and the community she serves.  
 
Plan  
The potential correlation between vitamin D and osteoporosis and osteopenia was 
identified and outlined. The project was implemented using PICO analysis at the doctorate 
level.  This quality improvement (QI) project utilized a quantitative retrospective study design 
involving 91 patients.  Outcome data was compared utilizing  patients who had previously 
undergone a bone density test using a DEXA scan and also had Vitamin D OH 25 laboratory 
testing over the previous three-year period.  The main outcome that was measured was the 
number of patients diagnosed with osteoporosis or osteopenia and the laboratory blood level 
value of vitamin D OH 25.  Other variables included DEXA scan results, vitamin D OH 25 
lab results, gender, age, steroid use history, and exercise history.  Using one-way ANOVA 
testing, the study identified four groups; once this was completed, multiple regression was 
used to analyze the variables involved.   
 
Outcomes and Measures 
The study consisted of 12 men and 79 women.  39% of patients had both osteoporosis or 
osteopenia and vitamin D deficiency, 36% of patients had osteoporosis or osteopenia and did 
not have vitamin D deficiency, 5% of patients had normal bone and were vitamin D deficient 
and 20% of patients had normal bone and normal vitamin D results.  Results of the one-way 
ANOVA test showed a significance of p=0.026 for vitamin D when compared to the control 
group diagnosis.  The results of this analysis show that vitamin D deficiency is a statistically 
significant factor in osteoporosis and osteopenia. The factor of vitamin D deficiency had a 
higher statistical significance than exercise history, steroid use, gender, and age. 
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Problem Recognition and Definition 
Statement of Purpose 
 The purpose of this capstone project was to identify a statistical significance between 
osteoporosis and osteopenia in the context of vitamin D deficiency and provide evidence that 
vitamin D deficiency contributes to osteoporosis and osteopenia. The knowledge gained from 
this project will hopefully raise provider awareness of the importance of detecting vitamin D 
deficiency and the relationship with osteoporosis and osteopenia in their patients.  Raising 
awareness and incorporating treatment into practice may subsequently reduce the risk of 
osteoporosis-related fractures and hospitalizations.  Patients who had undergone bone density 
testing using a dual energy x-ray absorptiometry (DEXA) scan and had a vitamin D OH 25 
blood test drawn over the previous three-year period were identified in this capstone project.  
Patients were also required to have documented levels of exercise and steroid history to be 
included in the study.  Steroid history use included patients taking prednisone or other steroid 
medications equivalent to 30 milligrams per day or greater over the previous six-month period 
or longer.  The levels of vitamin D and DEXA scan results were recorded to determine the 
relationship between vitamin D OH 25 levels and osteoporosis or osteopenia.   A quantitative 
retrospective study design was used to include all patients meeting the above mentioned 
criteria over the previous three-year period.  Establishing a correlation between vitamin D and 
osteoporosis or osteopenia may contribute to the improved treatment of patients and would be 
considered primary preventative medicine.    
Problem Statement 
Vitamin D deficiency is a concern, not only in the United States, but worldwide.  At 
the investigator’s primary practice in the southwestern United States (US), the providers had 
2 
 
noticed an increase in the incidence of osteoporosis that went undiagnosed.  The incidence of 
vitamin D deficiency in patients had also been acknowledged as a problem by the providers in 
this practice over the past few years.  The primary investigator had been cognizant of the 
incidence of vitamin D deficiency and a possible correlation to osteoporosis and osteopenia.  
Osteoporosis and osteopenia may result in weakened bone and fractures affecting the wrist, 
hip, and vertebrae (Lowe & Friedlaender, 2013). 
Several studies have demonstrated the significance of vitamin D deficiencies related to 
fractures and osteoporosis (Geriatrics Society Guidelines, 2014 and Johnson, Smith, Smith, & 
Sanzone, 2008).  A growing concern in the US is the incidence of hip fractures and 
periprosthetic fractures in the elderly and the vitamin D deficient (Leyland, 2013).  
Periprosthetic fractures occur during or after joint replacements or fracture repairs.  As a 
result, periprosthetic fractures may result in prolonged healing times.  Hip fracture patients are 
almost universally deficient in vitamin D (Hairon, 2005).  Hip fractures and periprosthetic 
fractures may result in increased morbidity, longer recovery periods, increased health care 
costs, and post-operative complications (Leyland, 2009).  Analysis of population data shows 
that patients with a diagnosis of osteoporosis and osteopenia are at a higher risk for fractures.   
Previous studies were used for comparison with similar data conducted on patients 
with osteoporosis and osteopenia and vitamin supplementation.  Meek, Norwood, Smith, 
Brenkel & Howie (2011) identified patients studied over a ten-year period and evaluated 
approximately 1000 patients yearly; on average, 10-15% of patients (mostly female) were 
positive for fractures.  Another study showed fractures averaged between 0.3%-4.2% in 
patients with osteoporosis and osteopenia (Boulton & Rodriquez, 2009).   
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Vitamin D is important to bone health due to its ability to help regulate parathyroid 
hormone, which then helps to regulate bone loss.  Vitamin D also contributes to stimulating 
intestinal and renal calcium absorption (Lowe & Friedlaender, 2013).  Therefore, preventative 
medicine plays an integral part in reducing health care costs (Terry, 2011) by lowering the 
risk of complications and hospital stays resulting from osteoporosis. 
PICO Question 
This capstone project was an evidence-based practice (EBP) project in which a quality 
improvement plan, program evaluation, educational, or standard of care intervention was 
completed.  In most cases, a pre-test and post-test evaluation will assess the effect of the 
intervention.  The project was internal to an agency and informed the agency of issues 
regarding health care quality, cost, and patient satisfaction.  The results of this project were 
not meant to generate new knowledge or be generalizable across settings, but rather seek to 
address a specific population, at a specific time, in a specific agency.  These projects translate 
and apply the science of nursing to the greater health care field.   
Projects utilize the acronym “PICO”, rather than stating a formal research hypothesis.  
The acronym stands for:  Population or Disease (P), Intervention or Issue of Interest (I), 
Comparison Group or Current Practice (C), and Outcome (O), and is usually framed as a 
question (Melnyk & Fineout-Overholt, 2011). 
The PICO question for this capstone project was: In osteoporotic or osteopenic 
patients, what is the relationship between reduced serum levels of vitamin D OH 25 compared 
to normal serum levels of vitamin D OH 25, in the incidence of osteoporosis or osteopenia? 
(Melnyk & Fineout-Overholt, 2011).  The original goal was to analyze data for up to 200 
patients throughout the six-month study period.  The population sample for this capstone 
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project consisted of 91 patients.  Since this was a retrospective study, patients were not asked 
to undergo testing for the purpose of this study.  Data extracted for the use of this study was 
existing data in patients previously screened with a DEXA scan and vitamin D OH 25 blood 
testing.  If these two tests had not been completed previously, the patient was excluded from 
the study.  Other variables were also included in this project and patients were required to 
have the following inclusion criteria documented in their charts: age, gender, exercise history, 
and steroid use history. 
Project Significance, Scope, and Rationale 
 According to Steven (2012), the incidence of periprosthetic fractures occuring intra-
operatevely and post-operatively is 1.5-4% in the US.  Another study by McGraw, Spence, 
Baird, Eckhardt & Ayana (2013) documented the incidence of periprosthetic fracture after hip 
arthroplasty to be 4%.  Patients commonly have documented low vitamin D OH 25 levels 
associated with a diagnosis of osteoporosis or osteopenia.  Two orthopedic surgeons at the 
primary investigator’s practice have documented the incidence of osteoporosis in hip fracture 
patients, and often recommend a different treatment plan for those patients, such as non-
weight bearing on the affected limb and delays in physical therapy with immobilization.  This 
altered treatment plan affects the patient’s recovery time and could all be prevented with a 
recent diagnosis of vitamin D deficiency or osteoporosis and proper supplementation.   
Osteoporosis contributes to an increased fracture risk in patients, which may be the 
result of an insufficiency in vitamin D.  Bogunovic, Kim, Beamer, Nguyen & Lane (2010) 
documented that all patients with fractures should be assessed for vitamin D 25 (OH), 
pointing out the importance of better management of hypovitaminosis to prevent fractures.  
Multiple studies have been performed showing fracture risk in osteoporosis (Geriatrics 
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Society Guidelines, 2014; Johnson, 2008; Lawrence, 2008); however, limited studies show 
evidence of research on vitamin D insufficiency and deficiency in these same patients.   
According to Bahlous, Farjallah, Bouzid, Klouz, Mohsni, Sahli, Lakhal, Sallami & 
Abdelmoula (2009), 45.2% of women tested in their study were found to be vitamin D 
deficient or insufficient. 
In a study conducted by Gallacher as reported by Hairon (2005), study leader Dr. 
Stephen Gallacher found that vitamin D inadequacy was a significantly correctable risk factor 
for fragility fractures.  
Meek, Norwood, Smith, Brenkel & Howie (2011) reported that the incidence of 
periprosthetic fracture after knee arthroplasty is 0.6-2.5% and 4% after revision arthroplasty.  
The incidence of periprosthetic fracture after hip arthroplasty was higher, at 1.1% and 4% 
after revision arthroplasty (Meek et al, 2011).  The article also documented that periprosthetic 
fracture after total hip and knee arthroplasty may be the second leading cause of revision after 
aseptic loosening.  It can be assumed that an overall reduction of hospitalizations from 
periprosthetic fractures and total revision arthroplasty will reduce the risk of secondary 
complications, such as pneumonia, stroke, cardiac events, and deep vein thrombosis.  
Reducing the risk of hospitalization will reduce overall healthcare costs.   
Theoretical Foundations 
The Community Nursing Practice Model and Betty Neuman’s System Model were 
analyzed for their appropriateness and were deemed applicable to this capstone project. The 
Community Nursing Practice Model is based upon the following concepts: respect for the 
person, people are caring, people are whole, and always connected to each other, their 
families and their community (Barry, Gordon & Lange, 2007).  The basis of the Community 
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Nursing Practice Model is formed by values and provides grounding for primary care patients.  
The patient is identified as an entirety, not simply a diagnosis or a problem.  The Community 
Nursing Practice Model identifies factors such as respect, caring, and wholeness of the patient 
(Barry et al, 2007).  Patients are encouraged to interact and participate in their diagnosis and 
care plan.  The Community Nursing Practice Model identifies values affecting primary care, 
such as access, empowerment, and community participation.  Health care is easily accessible 
and allows interaction and community education, as well as individual patient education.   
Empowerment through education and support gives patients a sense of responsibility 
for their own health and well-being, assuming patients are responsible for their medical 
treatment and empowering themselves through education.  If patients understand why they are 
being treated, the disease course of action, prevention, and community support, then they are 
better able to function independently and contribute to their own treatment and well-
being.  Patients will likely be proactive in primary preventative medicine by reducing their 
fracture risk through the use of vitamin D therapy in conjunction with bone density testing.  
When compared to the consequences of a hip or wrist fracture, this concept is simple.  If the 
Community Practice model is applied, a reduction in comorbidities could be expected, as well 
as a potential for a decrease in hospital stays.  A decreased number of hip fractures and 
periprosthetic fractures could also be predicted.  
Betty Neuman’s model focuses on patient care and treating the whole person, not 
simply treating the diagnosis.  Providers can sometimes be guilty of treating a diagnosis 
instead of the patient.  Neuman’s theory allows treatment in its entirety, as well as the health 
and welfare of the patient.  This model focuses on external environmental factors playing a 
large part in the treatment and response of the patient (Ross & Bourbannais, 
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1985).  Neuman’s model is considered multidisciplinary and universal.  The model can be 
applied to a multitude of different situations affecting health care, and can be applied to 
research, education, and nursing practice (Ross & Bourbannais, 1985).   
Neuman’s model allows for change in the future and emerging health care trends, such 
as the Affordable Care Act and state-run medical care.  Individuals are assessed and the 
nursing theory is used to identify stress, relationships, and their application to patients (Ross 
& Bourbannais, 1985).  The core of Neuman’s model consists of energy resources such as 
body temperature, genetics, weakness, ego, and response.  Patients are assessed using lines of 
resistance that represent stressors.  The purpose is to maintain patient stability through 
prevention.  Patients are asked to apply prevention by using a strategy of defense 
mechanisms, increase their resistance, and a return to wellness through the use of education.   
Patients should be educated on how to identify factors influencing osteoporosis or 
osteopenia and take an active role in their medical care.  External factors affecting the 
diagnosis of osteoporosis and osteopenia can include family history, smoking history, exercise 
history, steroid use, diet, supplement use, and menopausal age.  These factors are seldom 
similar, and if they are, the ensuing impact on the patient will not be similar. Thus, there is a  
justification for treating each individual as unique.  Using Neuman’s model, each patient 
should be educated on factors that they can control, such as smoking, caffeine use, weight 
bearing exercise, steroid use, and vitamin supplementation.  Patients should be participants in 
the review of their bone density results and understand how to read the study themselves.  
Patients could also potentially participate in a one-hour physical therapy session for weight 
bearing exercise training and prevention of further disease and fracture.  Patients should 
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ultimately be given the tools to prevent osteoporosis and osteopenia by assessing lifestyle and 
factors that may affect their diagnosis and reducing their exposure to these variables.   
Review of Evidence 
Background of the Problem 
A comprehensive literature review was completed and revealed a correlation for 
patients with low levels of vitamin D and patients with hip, wrist, and vertebral fractures.  
Multiple studies related to vitamin D deficiency in fracture patients were available for review.  
 In a retrospective study by Streit, Merle, Clarius & Aldinger (2011), a total of 354 
patients were analyzed, whereby 14 of these patients had periprosthetic fractures in relation to 
osteoporosis.  In another study reported by Meek, Norwood, Smith, Brenkel & Howie (2011), 
an evaluation of osteoporotic patients was completed over a ten-year period.  This particular 
study reviewed approximately 1000 patients yearly over a period of three years.  On average, 
10-15% of patients (mostly female) were positive for periprosthetic fractures.   
The scope of evidence supports an ongoing concern for identifying patients at risk for 
osteoporosis and osteopenia, which may result in a preventable fracture.  The incidence of 
osteoporosis and osteopenia contributes to fracture rates and may be preventable with the 
correction of vitamin D deficiency.  Bahlous et al (2009), noted that all fractures should be 
assessed for vitamin D 25 (OH), pointing out the importance of better management of 
hypovitaminosis to prevent fractures.   
According to Lowe & Friedlaender (2013), there is evidence associating vitamin D 
intake with fracture reduction.  In a meta-analyses study performed, oral vitamin D 
supplementation at any dose led to a 7% to 10% decrease in fracture risk.  In subjects who 
took the highest vitamin D doses, the reduction risk was greater (Lowe & Friedlaender, 2013).   
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Literature Review 
Systematic Review of the Evidence 
 During a systematic literature review performed by the primary investigator, 35 
articles were used to perform this capstone project.  The literature review consisted of articles 
containing information on vitamin D deficiency, calcium use, osteoporosis, osteopenia, and 
fractures related to weak bone.  The focus of the investigator during the literature review was 
to gather information on previous studies, which related to this capstone project.  Using 
information from studies in the literature review, the researcher was able to assess factors that 
had been identified as significant in previous studies.  The strongest factors relating to 
osteoporosis were identified as steroid use, exercise history, age, and gender.  For this reason, 
these factors were applied to this capstone project in conjunction with vitamin D deficiency.   
The articles for the literature review were gathered over a six-month period utilizing 
multiple resources, including search engines, peer reviewed articles, and key words that were 
pertinent to the project.  Key words used for the search included vitamin D deficiency, 
vitamin D, periprosthetic fracture, bone density testing, DEXA, osteoporosis, osteopenia, and 
hypo-vitaminosis.  In total, the search engine results located 26,000 articles.  After narrowing 
down from this vast search, 35 articles were then selected as the most appropriate articles by 
the primary investigator at her discretion as applicable to this project.  The search engines that 
were utilized included PubMed, Medline Plus and the Cumulative Index for Nursing and 
Allied Health (CINAHL).  All of these studies were used for data comparison and benchmark 
targets.  In total, 28 quantitative studies and seven qualitative studies were deemed to be the 
most applicable to this capstone project.  Of the 35 research articles,  the breakdown using 
Houser and Oman’s levels of evidence revealed 12 Level II studies, ten Level III, nine Level 
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IV, and four Level V studies and were referenced in the systematic review of literature during 
the second year of the doctorate of nursing practice program (Houser & Oman, 2011).   
In a study by Brady (2010), the author addressed the need for taking calcium and 
vitamin D, prevention of deficiency, and ultimately treatment of the deficiency.  The authors’ 
goal was to educate the public about vitamin D deficiency.  Vitamin D supplementation was 
recommended at doses of 800-4000 international units (IU) daily or 50,000 IU weekly (Brady, 
2010).  This study however, recommended a large range of vitamin D dosage instead of 
specific ranges based on laboratory values.  Another study recognized that one-year 
supplementation of vitamin D significantly decreased bone turnover.  This study noted a 
decrease in the incidence of osteoporosis and fractures (Herrmann, Kirsch, Kruse, Eckert, 
Graber & Obeid, 2010).  No specific dosing instructions were given, however, the study had 
93 participants and was performed over one year (Herrmann et al, 2010). 
Vitamin D3 and vitamin D2 were compared in an attempt to prove which supplement 
increased bone strength over 105 days (Macarena, Gonzales, Marote, Pellegrini, Pighin, 
Landeta, Lifshitzjj, Friedman, Mandalunis & Zeni 2009).  This study was inconclusive and 
used rats instead of humans.  The bone turnover rate over the research period of 105 days was 
not found to be significant enough to determine validity (Macarena et al, 2009).  According to 
Cashman (2012), severity of vitamin D deficiency has been more profound in the past several 
years.  In a study published in Food and Nutrition Research Journal, it was unclear whether 
vitamin D3 was more effective than vitamin D2, but a lack of overall vitamin D 
supplementation was recognized (Cashman, 2012).   
In a retrospective study that aimed to prove the importance of vitamin D beyond bone 
health (Marz, 2011), more data review was recommended based on the findings.  It was 
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determined that daily food intake was not sufficient enough to increase low vitamin D levels 
(Marz, 2011).  Vitamin D at doses of 4000-5000 IU daily was recommended as a safe and 
simple way to reduce vitamin D deficiency and improve bone health, as well as many other 
medical issues.   
In an expansive literature review study written by Fulvio, Marcello, Giorgio, Dallagio 
& Pablo Cada, (2010), it was reported that vitamin D was a significant contributor to 
osteoporosis and multiple body systems.  Singh et al (2012) conducted a literature review of 
40 patients to determine how many were diagnosed with osteoporosis and how many were 
vitamin D deficient.  The study noted about 80.6% of cases as vitamin D deficient and 42.5% 
of cases had documented osteoporosis of the spine (Singh et al, 2012).  A positive correlation 
was determined between vitamin D deficiency and low bone mineral density scores 
(Kritanjali et al, 2012).  This study was specific to thalassemia patients and the two variables 
were not cross referenced for further comparison.   
Another case control double blind trial studied two groups of patients all deficient in 
vitamin D.  Patients were treated with vitamin D supplementation with or without B vitamins 
added to the regimen.  This study found significant increases in vitamin D levels and a 
decrease in bone turnover in all patients regardless of the presence of B vitamins (Herrmann 
et al, 2010).  Dosing regimens also have an effect on vitamin D levels with serum levels 
increasing as dosage increases (Ivorra, Valls, Fernandez-Llanio, Comella, Chalmeta, Oliver & 
Roman-Ivorra, 2006).  Recommended vitamin D dosages between 600 IU and 3200 IU per 
day were considered optimal and contributed to adequate laboratory values (Ivorra et al, 
2006).        
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  Periprosthetic fractures are a significant complication caused by osteoporosis and 
may be preventable in patients undergoing elective and non-elective surgery.  Periprosthetic 
fractures are a significant contributor to increased health care costs (Higgins et al, 2009).  
Mortality risk is increased with revision after fracture and is a preventable surgical exposure 
(Young et al, 2008).  In two retrospective studies using literature review, it was determined 
that preventative medicine is far more cost effective to the health care system as well as 
reducing risk to patients (Higgins, Davis, Revell & Porter, 2009; Young, Walker & Pitto, 
2008).  In a study done by Dunbar, Howard, Bogoch, Parvizi & Kreder, 2009, they predicted 
less hip fractures by the year 2020 with a reduced incidence of osteoporosis.  More orthopedic 
surgeons are treating osteoporosis prior to joint replacement with vitamin D level screening as 
part of the correction process (Dunbar et al, 2009).   
A group of orthopedic surgeons conducted an observational study using retrospective 
review to identify 723 patients undergoing surgery over a 14-month period (Bogunovic et al, 
2010).  Strong recommendations were made in regards to vitamin D dosing prior to surgery 
after finding that almost half of the patients had low levels of vitamin D.  In a case control 
study, a non-specific correlation was determined between decreased bone density and vitamin 
D deficiency in patients with advanced osteoarthritis (Glowacki, Hurwitz, Thornhill, Kelly & 
Leboff, 2003).  The study did recognize a positive correlation between osteoarthritis, vitamin 
D, and osteoporosis (Glowacki et al, 2003).    
No studies were found in this literature review that used vitamin D as a factor 
contributing to osteoporosis and osteopenia when compared to other factors or directly 
comparing the two variables.  The studies utilized for the literature review recognized vitamin 
D and calcium supplementation as contributory factors for the prevention of osteoporosis and 
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osteopenia.  Previous studies recommended vitamin D supplementation of 400-600 IU per day 
for the prevention of osteoporosis and osteopenia (Lowe & Friedlaender, 2013).  The National 
Osteoporosis Foundation (NOF) has recently raised their recommended upper limit of vitamin 
D supplementation to 4000 IU daily due to the increased recognition of vitamin D deficiency.   
Project Plan and Evaluation 
Strengths  
 The primary investigator was able to obtain data by performing a retrospective data 
analyses on 91 patients to include multiple variables that may have contributed to the 
diagnosis of osteoporosis and osteopenia.  Comparing the variables to vitamin D deficiency 
and the diagnosis of osteoporosis, osteopenia and normal bone differentiated the strong and 
weak variables.  Variables assessed included age, gender, exercise history, and steroid use.  
Assessing multiple variables gives the study reliability and confidence to the reader. 
 The primary investigator had access to the data and focuses her expertise on 
rheumatologic and orthopedic patients in a private practice.  The primary investigator has 
access to osteoporotic patients and sees referrals in a large medical building consisting of 
neurology, orthopedics, neurosurgery, physical therapy, primary care, women’s health, and 
chiropractic care.  A bone density machine is located onsite for patient convenience.  The 
primary investigator had experience with vitamin D deficiency and osteoporosis and had been 
exposed to orthopedic patients undergoing both osteoporosis-related fractures and 
periprosthetic fractures occurring intra-operatively and post-operatively.  Frontline exposure 
to these orthopedic patients allowed the primary investigator basic knowledge and resources 
to conduct the study.       
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Weaknesses 
There was a margin of error and patients were excluded if they had not had a bone 
density test and a vitamin D OH 25 level drawn in the previous three-year period (Meek et al, 
2011).  Some patients were not included in the study if all variables were not available.  
Variables included exercise history, steroid use history, gender, age, diagnosis, and level of 
vitamin D OH 25 lab value.  Multiple patients were excluded from the study if they did not 
meet the criteria.  A larger number of patients may have given this study greater significance.  
Documentation was retrieved from their charts on file and accuracy is assumed based on 
patient reliability.   
Patients with smoking history were not assessed for this study.  Smoking history may 
be defined in a number of methods.  Smoking history can be categorized as direct exposure to 
smoke and indirect exposure to smoke.  Patient may have smoked while in their thirties 
suppressing bone turnover when it was at its peak, and subsequently quit smoking a few years 
later.  Due to difficulty assessing this variable, it was excluded from this study and may have 
contributed to the results.   
Opportunities 
 The study allows for recognition and correction of osteoporosis and osteopenia by 
acknowledging a treatable problem early on instead of treating patients with prescription 
strength medication at later stages.  Given the opportunity to recognize vitamin D deficiency 
at an earlier age and therefore prevent a future diagnosis of osteoporosis or osteopenia, it may 
allow the patient to reduce future long term prescription medication intake with potentially 
detrimental side effects and decrease the incidence of comorbidities.  Some patients have 
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difficulties tolerating these medications and are often trying to correct this diagnosis after they 
have been assessed as having osteoporosis or osteopenia or have fractured a bone.  
 This capstone project aimed to raise awareness to both providers and patients exposed 
to osteoporosis and osteopenia.  By recognizing and correcting the problem, primary 
preventative medicine will play an important role in the prevention of osteopenia and 
osteoporosis.  Using teaching methods, patients may benefit from a new protocol preventing 
further fracture, consistency in DEXA scanning, and reduced fracture risk.  Using primary 
preventative medicine before the diagnosis of osteoporosis or osteopenia or a fracture occurs, 
will help to reduce the incidence of osteoporosis-related fractures.   
Threats 
There were minimal threats to the study.  A larger database of patients may have 
resulted in stronger study results.  A larger database may have been achieved by documenting 
patient findings for the past five years instead of three years.  Incorporating another provider’s 
practice into the study may also have expanded the database.  However, strong correlation 
between vitamin D and osteoporosis and osteopenia was achieved nonetheless.  The primary 
researcher originally desired 200 applicable study patients and managed to achieve a 
population of 91.  Institutional Board Review (IRB) approval was received later than expected 
and changes were made to the original IRB.  The original study was changed from an 
experimental type study to a retrospective data analysis.   
Other considerations included the possibility that patients had already undergone a 
correction in vitamin D level, which may have been completed over the previous three month 
period. They still may have been given diagnosis of osteoporosis or osteopenia, which would 
have taken much longer to correct.  Most low vitamin D levels can be corrected within six 
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months, but osteoporosis and osteopenia can often take much longer to correct.  The 
possibility of this correction of vitamin D may have affected results of the study.   
Potential threats to validity and reliability to the project were few; volume of data was 
essential for high quality results.  A power of 0.80 was documented giving the study 
reliability and a confidence level of 95% in regards to the relationship between vitamin D and 
osteoporosis and osteopenia.  These results were accomplished using one-way ANOVA 
testing and comparing the variables independently, while also comparing variables to each 
other.  Zaccagnini and White. (2011), identified that project implementation is the exercise of 
leadership and control of the project.  The study gathered as much data as possible, but the 
ability to maintain the integrity of the project within a parameter that was controlled by a 
single investigator was crucial.  Missing or incomplete data was excluded from the study.  
Zaccagnini and White, (2011), recommended that the investigator  think about foreseeable 
and unforeseeable events.  Unforeseeable events may have included too few charts to review 
or time constraints relating to collecting information.  Other unforeseeable events were charts 
that lacked enough variables to meet all criteria and were then excluded.  A population of 
n=91 was achieved which was sufficient for study results and reliability.  A population of 
n=78 was desired for the strongest results. 
Driving and Restraining Forces 
Budget and resources were minimal to the primary researcher.  A retrospective data 
analysis was used, and therefore, data was readily available at no cost to the primary 
investigator.  An employee of the primary researcher contributed 20 hours of time for data 
collection and was able to complete the second review of information to verify data already 
collected by the primary investigator.  The verification of data by both the employee and 
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investigator ensured consistency and reliability.  The primary investigator devoted about 260 
hours to this capstone project for data collection and analyses.  The statistician cost for a 
project this size was quoted at $400-$500.  The statistician was not needed for this project as 
the primary researcher was able to use the Statistical Package for the Social Sciences (SPSS) 
version 22 statistics program with the help of an academic instructor and prior knowledge 
from a statistics course.  
Needs, Resources and Sustainability 
 There were several resources that became readily available to the researcher.  The data 
was collected using a data collection tool (see Appendix A).  Charts were then reviewed from 
the past three years utilizing existing data.  Patients were not asked to undergo testing for the 
purpose of this study.  Patients were asked to fill out a questionnaire prior to DEXA scan 
documenting the variables used for this study.  If all the variables were documented in the 
chart, the data was used.  If pertinent variables were not documented, the data was excluded 
and the patient was not used for this study.   
The primary investigator was able to use an employee knowledgeable with the 
practice charts.  SPSS v. 22 statistics were used for the analyses.  SPSS v. 22 was accessible 
at a cost of $50 and was already purchased for a statistics course.  Other resources included an 
Excel spreadsheet, which was also accessible to the primary investigator at no cost.  The 
resource of time was a large component.  The researcher spent over 260 hours and a medical 
assistant spent about 20 hours documenting data.  The charts were reviewed over a six-month 
time period.   
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Feasibility, Risks and Unintended Consequences 
 This capstone project identified multiple benefits in recognizing factors contributing to 
osteoporosis and osteopenia.  Several factors contribute to the diagnosis of osteoporosis and 
osteopenia.  Four factors were utilized for the purpose of this project, and were identified as 
age, gender, exercise history, and steroid use history.  Other patient factors could have 
included smoking history, family history of osteoporosis, age of menopause and fracture 
history but were not included for the purpose of this capstone project.  Calcium levels were 
also not used as a variable in this study and may have contributed to data findings.  Preventing 
osteoporosis may result in a decrease in fragility fractures and reduce comorbidity.  Risks to 
the study participants were minimal since this was a retrospective study.  There were no new 
interventions introduced and no new treatment was introduced before study completion. 
 As a result of the study, the researcher recognized that many of the bone density tests 
were outdated.  Patients were not being scheduled for bone density tests every one to two 
years depending on their diagnosis as is recommended.  It was acknowledged that continuity 
of care is a deficit and this could be addressed in the future.  Patients should have a bone 
density test for screening of osteoporosis or osteopenia every two years, starting at the age of 
65 years.  If patients are diagnosed with osteoporosis or osteopenia or have a new fracture, 
they should be offered a bone density test every year.    
Stakeholders and Project Team  
The project team for this capstone project was minimal and included the primary 
investigator, a capstone mentor who practices as an orthopedic surgeon, and one employee 
from the primary investigator’s practice that was used briefly for data collection.  The primary 
investigator was responsible for overseeing data collection and documentation.  The primary 
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investigator was also responsible for maintaining integrity of the project and patient 
confidentiality.  A medical assistant was used to help with data collection.  Data was retrieved 
from the charts and information was available within the practice.  The medical assistant was 
experienced in chart review. 
The stakeholders affected by retrospective data analyses and possible implementation 
of a new policy may include patients, families, providers, and insurance companies.  Patients 
have a vested interest in primary preventative medicine as well as their health and wellbeing.  
Preventing a fracture of the wrist, hip and vertebrae may result in less comorbidity, higher 
quality of life, and reduced co-pays to insurance companies (Johnson, 2008).   
A Hologic™ bone density machine is located at the office of the primary investigator.  
Providers at the primary investigator’s practice locations have the potential to make a profit 
on a new policy development with bone density reimbursement if rates increase from their 
current low reimbursement fee schedule.  DEXA scanner representatives such as Hologic™ 
have reported significantly less sales and renewals of leases on bone density equipment since 
the cuts in reimbursement (Johnson, 2008).  Patients undergoing regular bone density testing 
will be covered by most insurance plans, which consequently becomes a minimal 
reimbursement to the providers (King & Florentino, 2011).  Insurance companies may also 
benefit by preventing fractures that may result in hospitalizations, thereby saving Medicare 
and other insurance companies significant costs for hospitalization, surgery, and 
rehabilitation.   
Cost and Benefit Analysis 
According to Houser and Oman (2011), cost and benefit analyses are difficult to 
project in the early analyses phase of evidence-based practice.  The costs to the patients were 
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minimal due to the use of a retrospective chart analysis.  Charts were available to the primary 
researcher and this incurred no costs for the patients.  In the future, most insurance plans will 
cover the cost of bone density testing yearly or every two years depending on the patient’s 
history, diagnosis and symptoms.  The average cost of a bone density test billed to the 
insurance is $150, and reimbursement rates are approximately between $40 and $75.  Cash 
pay rates at the primary investigators practice is $60 per bone density scan.  Some of the 
patient identifiers in the investigator’s practice include smoking history, alcohol use, family 
history, fracture history, long-term use of high dose, and rheumatologic diagnosis.  At the 
primary researcher’s practice and most practices, the patient’s insurance would require 
authorization before the procedure could take place.  
Vitamin D supplementation usually costs between $5 and $20 per month.  Patients are 
typically advised to take supplementation based on their lab results after follow-up.  The 
Hologic™ bone density machine was purchased by the primary investigator at a cost of 
$50,000 and was available for lease over a five-year time period.  Using the diagnosis code of 
268.9, which is unspecified vitamin D deficiency in the International Classification of 
Diseases 9 (ICD-9) manual, most insurances cover the cost of the vitamin D OH 25 laboratory 
test.  The cash price for a vitamin D OH 25 laboratory test is typically between $150 and 
$250.   
Reducing the possibility of emergency room visits and hospital visits will have a 
tremendous effect on the patient and the healthcare system in general.  Emergency room visits 
and hospital stays can cost between $100 and $25,000, based on insurance and diagnosis.  The 
benefits of reducing hospital stays include avoiding surgery, immobilization, complications 
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secondary to surgery such as periprosthetic fractures, and reducing comorbidities (see 
Appendix B).   
Using retrospective study analyses, the researcher identified patients over the past two 
years who have had a bone density test and a vitamin D OH 25 lab level drawn.  Bone density 
testing was available on site for convenience to the patient.  The purpose of the study was to 
identify a correlation between osteoporosis and osteopenia findings on a bone density test and 
the incidence of vitamin D deficiency.  Identifying a correlation may help to identify patients 
at risk for osteoporosis and osteopenia and reduce the incidence of fractures.   
Mission and Vision 
The mission of this capstone project was to determine if there was a relationship 
between vitamin D deficiency and osteoporosis or osteopenia, which may lead to a decrease 
in bone density.  By determining a relationship between vitamin D deficiency and decreased 
bone density, it would allow the primary researcher to identify patients at risk and prevent 
further disease.  The vision for this study was to decrease the overall risk of osteoporosis and 
osteopenia in clinic patients with proper supplementation and prevention.  
Goals  
The goal of this study was to determine whether the relationship between vitamin D 
deficiency and osteoporosis or osteopenia was statistically significant.  The problem of 
vitamin D deficiency and the correlation with osteoporosis was identified and the project was 
implemented using a PICO analysis at the doctorate level.  Another goal was to reduce the 
overall incidence of the diagnosis of vitamin D deficiency, osteoporosis, osteopenia, and 
fragility fractures within the primary investigator’s practice with proper supplementation and 
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prevention.  An overarching goal of this study was to include as many patients’ data pertinent 
to the PICO question as possible.  
Process and Outcomes 
The purpose of the project was to evaluate the relationship between osteoporosis and 
osteopenia and low vitamin D OH 25 levels.  This project was an evidence-based practice 
(EBP) project in which a quality improvement plan, program evaluation, or simple 
educational or standard of care intervention (with post-test evaluation) was completed.  
Timeframe was an important aspect of the success of this study (see Appendix C).   Projected 
time frame included data collected over the previous three years with an anticipated 
completion date of July 1
st
, 2014.  Collaborative Institutional Training Initiative (CITI) 
training was completed by the primary investigator in the fall of 2012 (see Appendix D). The 
PICO question was completed February 2013 and oral capstone proposal presentation was 
completed October 2013.  A letter of support was obtained by the primary investigator’s 
physician mentor in the clinic where the capstone project took place in January 2014 and IRB 
submission was completed in February 2014 (see Appendix E).  Data analysis was completed 
between March 2014 and July 2014.  The final oral capstone defense presentation took place 
in August 2014 and was accepted.    
The process was implemented over a two-year study period with completion of the 
Doctorate of Nursing Practice degree requirements.  The capstone project was completed at 
the primary investigator’s practice with direction from a mentor and orthopedic surgeon at a 
secondary practice.  Outcomes affected the primary researcher’s personal practice and also the 
practice of the researcher’s partners and colleagues located in the same facility.  The mentor, 
practicing as an orthopedic surgeon has changed his practice guidelines due to study findings.  
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The providers that were affected by the outcomes included two orthopedic surgeons, a 
neurosurgeon, neurologist, primary care nurse practitioner, women’s health nurse practitioner, 
chiropractor, and several physical therapists.  The objective of this project was to determine 
the number of patients diagnosed with osteoporosis or osteopenia and vitamin D deficiency.  
Once this was accomplished, documented risk factors were evaluated to determine the 
correlation between the variables and the diagnosis of osteoporosis or osteopenia.      
Process Model 
 The process model for this capstone project (see Appendix F) outlines antecedent, 
independent and dependable variables in a clear manner.  The dependent variable was the 
diagnosis of osteoporosis, osteopenia or normal bone.  The independent variables were 
vitamin D levels, exercise history, age, gender, and steroid use history.  Relationships 
between dependent and independent variables in this study were analyzed and compared for 
optimal results.  Using one-way ANOVA testing variables were compared to the diagnosis.  
Statistical significance was identified and compared to the other variables. 
Antecedent variables occur prior to the occurrence of the independent and dependent 
variables that may influence the dependent variable.  Current protocols for initiating vitamin 
D therapy are poorly illustrated in guidelines.  Some primary care providers do not include 
testing in yearly screening.  Bahlous et al (2009), recognized that 45.2% of women tested in 
their study were found to be vitamin D deficient or insufficient.  Moderator variables 
influence the relationship between the independent and dependent variables.  Moderator 
variables would include patient age, gender, exercise history, steroid use history, vitamin D 
OH 25-lab value, and diagnosis after DEXA scan.  
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Extraneous variables interfere with or obfuscate the relationship between the 
dependent and independent variables.  Examples are similar to those listed above with a 
concern for patient compliance with supplement intake and education on their diagnosis.  
Patients may have compliance concerns with vitamins and medications.  According to a study 
by Porthouse (2005), patient non-compliance with taking bisphosphonates resulted in a 60% 
drop out rate.  Relationships between variables are multi-faceted and will directly impact each 
other based on the individual patient.  
Population Sampling and Parameters 
The population at highest risk for osteoporosis and vitamin D deficiency (vitamin D 
OH 25 lab value below 32 ug/dL) is the elderly population (Lawrence, 2008).  Population 
assessment included residents of all ages meeting the outlined criteria residing in the 
southwestern part of the US.  Population assessed was male or female, over the age of 50 
years, had a documented positive or negative history of steroid use and exercise history, had 
undergone bone density testing using a DEXA scan, and had vitamin D OH 25 laboratory 
testing over the previous two-year period.  The rationale for using the above-mentioned 
criteria is the increased risk of vitamin D OH 25 deficiency and osteoporosis in this target 
group (Leyland, 2012).  Patients were not asked to undergo testing for the purpose of this 
study.  Data utilized was retrospective data, and readily available to the primary investigator.    
Although the target population for this capstone project was older adults, the risk was 
minimal for any harm or discomfort.  The investigator focused on the outcomes of the 
relationship between vitamin D OH 25 blood levels and DEXA scan results through chart 
reviews, not by generating new data. The investigator ensured that personal identifiers were 
not collected linking individuals to the collected data.  All data was reported as aggregate 
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data.  The setting was an existing medical practice owned by the primary investigator.  The 
practice was established in 2010 and focuses on rheumatology with a specific specialty in 
osteoporosis.  The primary investigator owns a DEXA scanner and often tests vitamin D 
levels.  Referrals from partners and other practices are sent to the primary researcher.  Data 
was readily available to the investigator for this reason.  
Protection of Human Rights 
The protection of human rights is the responsibility of all health care providers, and 
patients are of primary concern at all times.  According to Zaccagnini and White (2011), when 
conducting nursing research, nurses must protect subjects right to privacy, self-determination, 
confidentiality, fair treatment, and protection from harm.  No unauthorized persons had access 
to this capstone project’s data.  Confidentiality was assured through a set of coding activities 
instituted by the primary investigator whereby no patient identifiers were on any of the 
instruments used to collect data for the study (see Appendix A).  Due to the nature of data 
collection for chart reviews, the primary investigator kept an Excel spreadsheet on a password 
protected computer with patient name and chart number and the de-identified code used on 
the chart review instruments to determine which patients’ charts had been reviewed.  Only the 
primary investigator had access to the data.   
Instrumentation Reliability and Validity of Intended Statistics 
Reliability is the degree of consistency or dependability with which an instrument 
measures the attribute it is designed to measure (Polit, 2011).  Literature review supported the 
findings and show consistency with results.  The researcher chose this study due to her 
experience with the increased incidence of vitamin D deficiency in relation to osteoporosis 
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and osteopenia.  Data will be kept for three years following the study and is available for 
review at request.   
Validity is a quality criterion referring to the degree to which inferences made in a 
study are accurate and trustworthy (Polit, 2011).  Evidence of validity will be shown 
throughout the study with evidence-based research in comparison to research findings.  All 
data collected will remain in a database for a period of three years for validity purposes.  Two 
researchers verifying the data on three occasions accomplished validity and reliability.  The 
primary researcher verified data on the first and third occasion and an assistant verified the 
data on a second occasion.   
Instrumentation was created for this capstone project (see appendix A) and was 
utilized for all patients included in the study and included information such as gender, age, 
diagnosis, vitamin D level, exercise history, and steroid use.  The primary investigator for this 
capstone project designed the instrument.  A power analyses of 0.80 was used and a 
confidence interval of 95% was achieved using the independent variable vitamin D when 
compared to the dependent variable of osteoporosis, osteopenia and normal bone.  A 
population of 78 was desired after performing the power analyses and a population of 91 was 
achieved.   
Data Collection and Procedure Protocol 
This quality improvement (QI) project utilized a quantitative retrospective study 
design comparing outcome data on patients who have previously undergone a bone density 
test using a DEXA scan and vitamin D OH 25 laboratory testing over the previous three-year 
period.   Blood values were categorized as vitamin D deficient or normal.  Data collected 
wherein nominal measurement is the lowest form of measurement and involves using 
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numbers (Polit, 2011).  Variables measured included a dependent variable of the diagnosis of 
osteoporosis and multiple independent variables, the diagnosis of vitamin D lab value, age, 
exercise history, gender, and past history of corticosteroid use. 
The researcher chose a quantitative study because data was categorized as numerical.  
When presenting data or reading data the researcher found it simpler to present data in 
numeric form to prove research findings.  Quantitative data is proof of a recorded lab value or 
proof that a patient has a tangible diagnosis of osteoporosis, osteopenia or normal bone 
quality.  When a DEXA score is reviewed with a patient it is straightforward and 
unquestionable.  Patients either have osteoporosis or they do not, and they either have vitamin 
D deficiency or they do not.   
The researcher used an Excel spreadsheet to collect data (Polit, 2010).   Using one-
way analyses of variance (ANOVA) for this study the variables were analyzed. Once this was 
completed, multiple regression was utilized to analyze the variables individually.  The 
variables were then separated into four categories: (1) patients with osteoporosis or osteopenia 
and low vitamin D levels, (2) patients with osteoporosis or osteopenia and normal vitamin D 
levels, (3) patients with normal bone and low vitamin D levels and (4) patients with normal 
bone and normal vitamin D levels.   
The software used for data analysis was SPSS v. 22.  Presentation was displayed in the 
form of one-way ANOVA analyses.  Graphing was attempted but due to the multiple 
variables involved, graphing was not successful.  Percentages were used for data presentation 
and ease of understanding for the reader.   
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Project Findings and Results 
Objective 
 The objective of this capstone project and data analysis was to determine whether 
vitamin D deficiency was statistically significant for the diagnosis of osteoporosis and 
osteopenia.  Other variables including exercise history, steroid use, gender, and age 
contributed to study findings.  Involving these variables, the researcher was able to 
demonstrate the significance of vitamin D on osteoporosis and osteopenia using descriptive 
statistics.  Descriptive statistics used were general statistics, one way ANOVA testing, and 
percentages.  A key was utilized (see Appendix G) to simplify the terms entered into SPSS v. 
22 for the ANOVA and a legend was developed (see Appendix H) to enter the data into SPSS 
v. 22.  
 One-way ANOVA testing was used to represent data.  The ANOVA test is used to 
analyze the difference between two means.  ANOVA tests analyze variation among groups, 
they are determined by the ratio of two variances.  A p-value was set at 0.05 and would give 
the researcher a significance level of 95%.  A result less than 0.05 would give the researcher 
95% confidence that vitamin D is a significant contributor to the diagnosis of osteoporosis or 
osteopenia.  The following one-way ANOVA test was run with vitamin D as the variable and 
showed a significance level of p=0.026.  
 
Table 1 (ANOVA #1) 
POPE   
 
Sum of 
Squares df Mean Square F Sig. 
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Between 
Groups 
2.550 1 2.550 5.107 0.026 
Within Groups 44.439 89 0.499   
Total 46.989 90    
 
This one-way ANOVA test was run with the variable age and was not statistically 
significant with a significance level of p=0.5888.  This value is above the p-value set at 0.05. 
Table 2 (ANOVA #2) 
POPE   
 
Sum of 
Squares df Mean Square F Sig. 
Between 
Groups 
1.022 3 0.341 0.645 0.588 
Within Groups 45.967 87 0.528   
Total 46.989 90    
 
This one-way ANOVA test was run with the variable steroid use and was not 
statistically significant with a significance level of p=0.364.  This value is above the p-value 
set at 0.05. 
 
 
Table 3(ANOVA #3) 
POPE   
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Sum of 
Squares df Mean Square F Sig. 
Between 
Groups 
0.436 1 0.436 0.834 0.364 
Within Groups 46.553 89 0.523   
Total 46.989 90    
 
This one-way ANOVA test was run using the variable gender and was not statistically 
significant with a significance level of p=0.413.  This value is above the p-value set at 0.05. 
Table 4 (ANOVA #4) 
POPE   
 
Sum of 
Squares df Mean Square F Sig. 
Between Groups 0.347 1 0.347 0.678 0.413 
Within Groups 42.547 83 0.513   
Total 42.894 84    
 
This one-way ANOVA test was run using the variable exercise history and was not 
statistically significant with a significance level of p=0.990.  This value is above the p-value 
set at 0.05. 
Table 5 (ANOVA) 
POPE  
 
Sum of 
Squares df 
Mean 
Square F Sig. 
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Between 
Groups 
.011 2 .006 .010 .990 
Within Groups 46.978 87 .540   
Total 46.989 89    
 
Table 6 (Statistics) 
 POPE VITD EXER STER AGE GENDER 
N Valid 91 91 85 90 91 91 
Missing 0 0 6 1 0 0 
Mean 0.9890 0.4396 0.4353 0.7000 0.8681 1.5385 
Std. Error of 
Mean 
0.07575 0.05232 0.05410 0.06787 0.03566 0.08882 
Std. Deviation 0.72256 0.49908 0.49874 0.64390 0.34022 0.84732 
Variance 0.522 0.249 0.249 0.415 0.116 0.718 
Range 2.00 1.00 1.00 2.00 1.00 3.00 
Minimum .00 .00 .00 .00 .00 .00 
Maximum 2.00 1.00 1.00 2.00 1.00 3.00 
 
The table above represents statistical analysis with mean of variables, standard 
deviation and variance.   
Table 7 (Patients analyzed) 
Osteoporosis/osteopenia and vitamin D 
deficient 
35 patients 
Osteoporosis/osteopenia and normal vitamin D 33 patients 
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Normal bone and vitamin D deficient 5 patients 
Normal bone and normal vitamin D 18 patients 
 
Of the 91 patients analyzed, 12 patients were men and 79 patients were women.  39% 
of patients had both osteoporosis or osteopenia and vitamin D deficiency.  36% of patients 
had osteoporosis or osteopenia and did not have vitamin D deficiency.  5% of patients had 
normal bone and were vitamin D deficient.  20% of patients had normal bone and normal 
vitamin D lab value.  These results show that the majority of patients evaluated in the study 
were diagnosed with osteoporosis or osteopenia and also had low vitamin D levels. 
Results of the one-way ANOVA test using variables of diagnosis and vitamin D levels 
showed a significance of 0.026 for vitamin D when compared to the control group diagnosis.  
A significance of 0.026 was below the p-value of 0.05 indicating a 95% confidence of 
accuracy and leaving a 5% possibility of error.  A significance of .0588 for gender, 0.364 for 
age, 0.990 for steroid use and exercise 0.413 was found when compared to the control group.  
All other variables were not statistically significant to osteoporosis or osteopenia.  These 
results show that vitamin D was the only variable that was statistically significant to the 
diagnosis of osteoporosis and osteopenia.  The other variables had no statistical significance 
in this study but the project investigator found clinical significance in these other variables.   
Results of the multiple regression test verified statistical significance with only one 
variable, which was vitamin D.  A confidence interval is the measure of reliability of an 
estimate.  If the value between the ranges of a confidence interval can equal 1, the researcher 
can assume the result is likely to occur.  A narrow window with the ability to achieve 1 gives 
the researcher more confidence in the significance of their results.  Multiple regression testing 
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was run using all of the variables and comparing the variables to each other.  The results 
showed the statistical significance of vitamin D on osteoporosis and osteopenia.  The 
variables when compared to each other showed no statistical significance.  The variable 
vitamin D deficiency resulted in a confidence interval of 0.290 and 2.082.  Confidence 
intervals of diagnosis of osteoporosis and osteopenia were 0.236-4.645.  All other variables 
showed a confidence interval that did not achieve 1.  All other factors could have been 0 and 
were not statistically or clinically significant in this study.  Vitamin D was the only variable 
that showed a confidence interval between 0 and 1.  
The standard deviation measures the amount of variation from the average.  Standard 
deviations were as follows: osteoporosis, osteopenia and normal bone had a standard 
deviation of 0.72256, vitamin D levels had a standard deviation of 0.49908, exercise had a 
standard deviation of 0.49874, steroid use had a standard deviation of 0.64390, age had a 
standard deviation of 0.34022 and gender had a standard deviation of 0.84732.  
Table 8 (Parameter Estimates) 
 Estimate Std. Error Wald df Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
Threshold [POPE = .00] .023 1.089 .000 1 .983 -2.111 2.157 
[POPE = 1.00] 2.440 1.125 4.707 1 .030 .236 4.645 
Location [VITD=.00] 1.186 .457 6.725 1 .010 .290 2.082 
[VITD=1.00] 0
a
 . . 0 . . . 
[EXER=.00] .724 .461 2.472 1 .116 -.179 1.627 
[EXER=1.00] 0
a
 . . 0 . . . 
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Analyses of the results showed a statistical significance between osteoporosis or 
osteopenia and vitamin D deficiency.  Vitamin D was the only variable that contributed to the 
diagnosis of osteoporosis and osteopenia.  All other variables did not contribute to the 
diagnosis.  The p value is the measure of how likely the data is to be accurate.  A p-value of 
0.05 gives the researcher 95% confidence that the results are accurate and not a matter of 
chance.  The p value was set at 0.05 and the statistical significance was 0.026 between the 
diagnosis of osteoporosis or osteopenia and vitamin D levels.  This significance level was 
below the p value, showing a confidence level of 95%.  The results showed that exercise, age, 
gender, and steroid use were not statistically significant factors in osteoporosis and 
osteopenia, but found to have clinical significance.   
The effect size is the size of the experimental effect; they allow the researcher to 
compare the magnitude of experiments to each other (Polit, 2010).  The effect is essentially 
the difference between the two means.  The effect size was calculated using 0.9890 (means of 
[STER=.00] -.115 .785 .022 1 .883 -1.653 1.423 
[STER=1.00] .038 .799 .002 1 .962 -1.528 1.605 
[STER=2.00] 0
a
 . . 0 . . . 
[AGE=.00] .765 .634 1.455 1 .228 -.478 2.008 
[AGE=1.00] 0
a
 . . 0 . . . 
[GENDER=.00] -.313 .921 .115 1 .734 -2.118 1.493 
[GENDER=1.00] .485 .762 .406 1 .524 -1.008 1.979 
[GENDER=2.00] -.260 .735 .125 1 .724 -1.701 1.181 
[GENDER=3.00] 0
a
 . . 0 . . . 
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control group POPE) subtracted by 0.4396 (means of experimental group VITD) divided by 
0.07575 (the standard deviation) =0.964.  The effect size is therefore, 0.964.  This result was 
close to one, indicating a larger affect of the experimental on the control.  When variables 
were compared to each other using correlation testing, there was no statistical significance.   
Limitations 
One limitation of the project was that although the other factors when compared to 
vitamin D were not statistically significant, some were more significant than others.  Age, 
exercise history, and gender were more significant than steroid use history.  Another 
limitation was that there was a large sample of women in the project as compared to men.  
Osteoporosis commonly affects women more often than men, however the population 
sampling may suggest that an increased provider awareness may be needed for the proper 
screening of men.   
Patients may have had previously corrected vitamin D levels with a diagnosis of 
osteoporosis or osteopenia.  Vitamin D levels may have been corrected over a period of three 
months.  Osteoporosis and osteopenia would take much longer for correction.   
Another limitation may have been that a larger sample size could have achieved 
stronger results.  The results of the study, however, indicated a strong correlation between 
vitamin D deficiency and osteoporosis and osteopenia.   
Smoking history was not included in the study for several reasons.  Smoking history 
can be documented as present or past history.  Patients achieve their highest bone turnover 
rate during their twenties and thirties; therefore, if patients smoke during this time, bone 
quality can be affected.  This smoking history documentation proved difficult to acquire and 
was therefore excluded from the study.   
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Other variables to include in a future study may be family history of osteoporosis and 
osteopenia, menopausal age, and supplementation such as calcium.  These factors may have 
increased or decreased the statistical significance depending on the findings.  
Recommendations 
The results of this analysis show that vitamin D deficiency is a statistically significant 
factor in osteoporosis and osteopenia.  The factor of vitamin D deficiency had a higher 
statistical significance than exercise history, steroid use, gender, and age.  All patients 
undergoing bone density testing should have a vitamin D OH 25-lab value.  All patients 
should be educated and screened for the prevention of vitamin D deficiency and also 
osteoporosis and osteopenia.  Patients diagnosed with osteoporosis or osteopenia are at risk 
for vitamin D deficiency and should have a vitamin D OH 25 lab draw completed once they 
are diagnosed with osteoporosis or osteopenia.  Patients undergoing bone density testing 
every other year should have a vitamin D level drawn at least once yearly.  If patients are 
deficient in vitamin D, they should be treated with an appropriate dosage of vitamin D and 
rechecked with a blood test after three months of treatment.    
 This capstone project demonstrates the importance of primary preventative medicine 
as an integral part of nursing.  New data was generated as a result of this study.  Prevention 
should start at the primary care level and patients should be screened yearly for vitamin D 
levels and osteoporosis and osteopenia, at minimum.  Patients screened should include post-
menopausal women, smokers, caffeine users, rheumatology patients, fracture patients, a 
strong family history of osteoporosis, and the elderly over the age of sixty-five years.    
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Implications For Change 
New protocols developed within the primary investigator’s practice include screening 
all new and existing patients for the date of their last bone density test and vitamin D OH 25 
lab value.  Patients are scheduled for a follow-up visit to review results within two weeks of 
their study completion.  Patients are educated on how to read a bone density and 
understanding their T-Score.  The T-Score indicates the strength of the bone when compared 
to a healthy 30-year old.  T-Scores above -1 indicate normal bone, between -1 and -2.5 
indicate osteopenia and below -2.5 indicate a diagnosis of osteoporosis.  Patients are given a 
copy of their bone density test on request and educated on prevention.  Most patients will 
undergo a one-time physical therapy visit for teaching on the prevention of osteoporosis and 
osteopenia.  Patients are given literature for educational purposes and scheduled for a follow-
up visit within one year if results are positive or indicate osteopenia with a possible vertebral 
fracture and two years if results are normal.  An indication for testing prior to two years 
would be new onset fracture or new exposure to long term steroids such as prednisone.  
Having this research available may educate patients and family and allow them to benefit 
from a study performed by their own provider.  
Future studies may include adding more variables such as smoking history, age of 
menopause and fracture history.  Another study could include evaluating the impact of 
calcium and vitamin D or calcium independently.  Research can be used to change practice 
guidelines and apply new protocols and recommendations.   
This study may be useful for conference involvement such as the National 
Osteoporosis Foundation (NOF), the American Association of Nurse Practitioners (AANP), 
the American Osteopathic Board of Orthopedic Surgery (AOBOS), the American Osteopathic 
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Academy of Orthopedics (AOAO), the American Academy of Orthopedic Surgeons(AAOS) 
and the American College of Rheumatology (ACR). 
Conclusion 
The purpose of this capstone project was to evaluate osteoporotic and osteopenic 
patients, and investigate “What is the relationship between reduced serum levels of vitamin D 
OH 25 compared to normal serum levels of vitamin D OH 25, in the incidence of osteoporosis 
or osteopenia?”   The goals of the study were met and it was determined that there was a 
relationship between vitamin D deficiency and osteoporosis or osteopenia, which was 
statistically significant.  Using one-way ANOVA testing, multiple regression and percentages, 
the researcher showed that vitamin D was statistically significant to osteoporosis and 
osteopenia.  Results of the one-way ANOVA test showed a significance of p=0.026 for 
vitamin D when compared to the control group diagnosis.  Results of the multiple regression 
test verified statistical significance with only one variable, which was vitamin D deficiency.  
This study showed that vitamin D deficiency as a variable was more significant to 
osteoporosis and osteopenia than the other variables such as exercise history, steroid use, age, 
and gender.   
Prevention of osteoporosis and osteopenia can reduce the risk of comorbidities such as 
fracture.  Identifying pertinent variables and treating patients for vitamin D deficiency can 
reduce the risk of fracture.  Osteoporosis and osteopenia have impacted patients and their 
families across the U.S. and across the world.  Primary preventative medicine plays an 
important part in treating patients and identifying the issue before disease occurs.  
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Appendix A 
                                              Retrospective Chart Review Instrument 
 
Patient identifier number:_______________________ 
 
Date of bone density test:_______________________________ 
 
Bone density test or result on file:  Y      N 
 
Patient bone density:  normal range    osteopenic        osteoporotic 
 
Vitamin D OH 25 level:________________________________ 
 
Patient age:_____________________________ 
 
Male________Female__________ 
 
History of steroid use: Y____  N_____ 
 
Current weight bearing exercise sessions per week:______________ 
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Appendix B 
Cost Analysis 
Item Cost 
Vitamin supplementation $5-$20 depending on size of bottle 
Calcium supplementation $4-$15 depending on size of bottle 
DEXA Scan per patient $60 cash price/co-pay if billed to insurance 
Hologic™ DEXA scanner $50,000  
Medication to treat osteoporosis Varies depending on medication  
Educational brochures from the Arthritis 
Association 
$20/pack of 30 brochures 
Primary researchers time commitment 260 hours 
Employee hours 20 hours/$11 per hour 
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Appendix C 
Timeline for Capstone Project 
 
STEPS Goals Due Date 
STEP I: Problem 
Recognition 
 
NR701/706A/707  
Identified Need  
Problem Statement-PICO 
PICO Approval 
Literature Review 
Fall 2012 
Spring 2013 
 
Spring 2013 
Spring 2013 
STEP II: Needs 
Assessment 
 
 
 
 
 
 
NR703/704/707 
Identify 
population/community  
Identify sponsor& 
stakeholders  
Organizational assessment  
Assess available resources  
Desired outcomes  
Team selection  
Cost/Benefit analysis  
Define scope of project 
Winter 2012 
 
Winter 2012/Spring 2013 
 
STEP III: Goals, 
Objectives, & Mission 
Statement 
 
NR707/711/721 
Goals  
Process/outcome objectives  
Develop mission statement 
 
STEP IV: Theoretical 
Underpinnings 
NR701/707/721 
Theories of change  
Theories to support project 
framework 
Fall 2013 
Fall 2013 
STEP V: Work Planning  
 
NR707/721/722 
Project proposal  
Project management tools  
Milestones  
Timeline  
Budget 
Fall 2013 
 
 
Summer 2013 
Spring 2013 
Summer 2013 
STEP VI: Planning for 
Evaluation 
 
NR706B/707/722 
Development evaluation 
plan  
Logic model development 
Fall 2013 
 
 
Fall 2013 
STEP VII: 
Implementation 
 
NR706B/706C/707/722 
IRB approval  
Threats and barriers  
Monitoring implementation 
phase  
Project closure 
Summer 2013 
Summer 2013/Fall 2013 
Fall /Winter2013 
Spring 2014 
STEP VIII: Giving 
Meaning to the Data 
 
Quantitative Data Summer 2014 
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NR702 
STEP IX: Utilizing & 
Reporting Results 
 
NR706C 
Written dissemination  
Oral dissemination  
Electronic dissemination 
Summer 2014 
Summer 2014 
Summer 2014 
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Appendix D 
 
CITI Training 
LEARNER DEPARTMENT EMAIL INSTITUTION EXPIRATION DATE 
COLLABORATIVE INSTITUTIONAL TRAINING 
INITIATIVE (CITI) 
HUMAN RESEARCH CURRICULUM COMPLETION REPORT Printed on 
02/09/2014 
SUMMER TILGNER (ID: 3218849) Nursing  stilgner@regis.edu  Regis University 
SOCIAL BEHAVIORAL RESEARCH INVESTIGATORS AND KEY PERSONNEL 
COURSE/STAGE: PASSED ON: REFERENCE ID: 
REQUIRED MODULES 
Introduction  History and Ethical Principles - SBE The Regulations - SBE  Assessing Risk - 
SBE  Informed Consent - SBE  Privacy and Confidentiality - SBE Regis University 
Basic Course/1 11/25/2012 9228460 
11/25/2015 
 
For this Completion Report to be valid, the learner listed above must be affiliated with 
a CITI Program participating institution or be a paid Independent Learner. Falsified 
information and unauthorized use of the CITI Progam course site is unethical, and may 
be considered research misconduct by your institution. 
Paul Braunschweiger Ph.D. Professor, University of Miami Director Office of Research 
Education CITI Program Course Coordinator 
DATE COMPLETED 
11/25/12 11/25/12 11/25/12 11/25/12 11/25/12 11/25/12 11/25/12 
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Appendix E 
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Appendix F 
Process Model 
 
 
                                                                                                                           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antecedent Variable 
Vitamin D for preventative 
treatment of osteoporosis and 
osteopenia 
Independent Variable 
Vitamin D, exercise 
history, age, gender, 
steroid use history  
Dependent Variable 
Diagnosed of 
osteoporosis, osteopenia 
or normal bone 
Moderator Variable 
Age, gender, exercise and 
steroid history 
Independent Variable 
Vitamin D   
Dependent Variable 
Diagnosis of 
osteoporosis, 
osteopenia, normal bone 
Extraneous Variable 
Age, gender, exercise and 
steroid use history 
Dependent Variable 
Decrease in amount of 
patients diagnosed with 
osteoporosis/osteopenia 
and fractures associated 
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Appendix G 
Key 
POPE: Osteoporosis, osteopenia and normal bone       
VITD: Vitamin D deficiency and normal lab 
EXER: Exercise history 
STER: Steroid use 
AGE: Age in categories                          
GENDER: Gender male or female 
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Appendix H 
Legend   
1. Diagnosis (POPE): 
Osteoporosis=0 
Osteopenia=1 
Normal=2 
2.  Exercise (EXER): 
No=0 
Yes=1 
Unknown=2 
3.  Steroid Use (STER): 
No=0 
Yes=1 
Unknown=2 
4.  Gender (GENDER): 
Male=0 
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Female=1 
5.  Vitamin D Levels (VITD) 
Normal Lab=0 
Vitamin d deficient=1 
6.  Age (AGE):  
50-60=0 
60-70=1 
70-80=2 
80-90=3 
90+=4  
 
 
 
 
 
 
 
